Development of LNA14 analytical methods and upstream and downstream processes for manufacturing, and scale-up manufacturing and release testing of the purified LNA14 product
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $799,780
Award facts
- Contract value 100% obligated
- $799,780.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $314,492 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $485,288 |
About this award
This is a $799,780 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the development of analytical methods, upstream and downstream manufacturing processes, scale-up production, and release testing for the LNA14 product. This delivery order falls under a larger Preclinical Services for Biopharmaceutical Product Development indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. No set-aside designation was indicated. Resilience Government Services has previously provided goods and services related to medical countermeasure development, pharmaceutical manufacturing, and chemical/biological defense programs through past federal contract awards.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Resilience Government Services, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 28, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $799,780 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under HHSN272201600006I, an indefinite delivery contract, on Preclinical Services for Biopharmaceutical Product Development.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award